The changing paradigm for cystic fibrosis in rhinology
Volume: 63 - Issue: 4
First page: 385 - Last page: 385
A.R. Sedaghat
DOI: 10.4193/Rhin25.904
I would like to welcome you to the August issue of Rhinology. In the latest issue of Rhinology, you will find high quality articles spanning the entire breadth of the field of rhinology. From studies on inflammatory sinus disease to skull base pathology, from medical to surgical treatments, every reader is sure to find studies of interest and applicability to their practice. For the focus of this editorial, I highlight for the reader the article by Le Bon et al., which describes the case of a patient with cystic fibrosis (CF) and chronic rhinosinusitis (CRS) with nasal polyps in whom concomitant NSAID-exacerbated respiratory disease (NERD) was uncovered after the initiation of triple combination CFTR modulatory therapy with elexacaftor-tezacaftor-ivacaftor (ETI).
Rhinology 63-4: 385-385, 2025
